Alto Ingredients

US Biofuel Markets Will Suffer From Volatility Yet Recover

AnalystLowTarget

Not Invested

Community Contributor

Published

28 Aug 25

Updated

12 Dec 25

Views

n/a

AnalystLowTarget's Fair Value

n/a

66.7%

-4.7%

66.7%

-4.7%

You can edit this narrative until Dec 13 4:20 AM. Then, changes will post as Updates.

Author's Valuation

US$318.3% undervalued

AnalystLowTarget Fair Value

Narrative

Updates1

Shared on 12 Dec 25

Fair value Increased 20%

ALTO: Lower Discount Rate Will Support Improved Risk Profile Ahead

Analysts have raised their price target on Alto Ingredients by about $0.50, citing a lower perceived risk profile driven by a reduced discount rate, stronger expected revenue growth, and a modest improvement in projected profit margins and future valuation multiples. Analyst Commentary Bearish analysts remain cautious on Alto Ingredients despite the recent upward revision to the price target, emphasizing that the new target still embeds a meaningful discount to peers on key growth and profitability metrics.

AnalystLowTarget Fair Value

US$3

18.3% undervalued

Future estimation in

Growth p.a.

Decrease

Increase

Current revenue growth rate

6.62%

Chemicals revenue growth rate

0.58%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

8.52%

Calculation

US$103.57m

Earnings '28

2.93x

PE Ratio '28

US$303.04m

Market Cap '28

US$303.04m

Market Cap '28

79.58m

No. shares '28

US$3.81

Share Price '28

US$3.81 Share Price '28

Discounted to 2025 @ 8.54% p.a.

US$2.98

Fair Value '25